Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP224666.RAZGyQOQQKs8EafqYnjBu3Br4tgARicWJZYnYAtALl9lw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP224666.RAZGyQOQQKs8EafqYnjBu3Br4tgARicWJZYnYAtALl9lw130_assertion type Assertion NP224666.RAZGyQOQQKs8EafqYnjBu3Br4tgARicWJZYnYAtALl9lw130_head.
- NP224666.RAZGyQOQQKs8EafqYnjBu3Br4tgARicWJZYnYAtALl9lw130_assertion description "[Both AM and AM2/IMD immunoreactivity were detected mainly within cancer cells, whereas MMP-9 immunoreactivity was mostly seen in the surrounding stroma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP224666.RAZGyQOQQKs8EafqYnjBu3Br4tgARicWJZYnYAtALl9lw130_provenance.
- NP224666.RAZGyQOQQKs8EafqYnjBu3Br4tgARicWJZYnYAtALl9lw130_assertion evidence source_evidence_literature NP224666.RAZGyQOQQKs8EafqYnjBu3Br4tgARicWJZYnYAtALl9lw130_provenance.
- NP224666.RAZGyQOQQKs8EafqYnjBu3Br4tgARicWJZYnYAtALl9lw130_assertion SIO_000772 21839130 NP224666.RAZGyQOQQKs8EafqYnjBu3Br4tgARicWJZYnYAtALl9lw130_provenance.
- NP224666.RAZGyQOQQKs8EafqYnjBu3Br4tgARicWJZYnYAtALl9lw130_assertion wasDerivedFrom befree-20150227 NP224666.RAZGyQOQQKs8EafqYnjBu3Br4tgARicWJZYnYAtALl9lw130_provenance.
- NP224666.RAZGyQOQQKs8EafqYnjBu3Br4tgARicWJZYnYAtALl9lw130_assertion wasGeneratedBy ECO_0000203 NP224666.RAZGyQOQQKs8EafqYnjBu3Br4tgARicWJZYnYAtALl9lw130_provenance.